The abstract is read at the publisher; the summary is JClub's.
AAV-based functional testing in Otof -/- mice shows that homozygous E1700Q confers normal hearing, while K1992R is linked to abnormal otoferlin localization in patients.
- Why it matters: OTOF VUSs block diagnosis and limit gene-therapy eligibility for about half of 135 hearing-loss patients with biallelic OTOF variants, slowing trial enrollment.
- What they did: The translational pipeline functionally evaluates coding VUSs by AAV-mediated variant delivery into Otof -/- mice and tests non-coding VUSs with splicing assays. It reclassifies eight representative VUSs to support clinical decisions.
- The result: The pipeline enables definitive molecular diagnoses for 38 patients and expands eligibility, with seven treated patients showing auditory improvement, including one near-normal hearing sustained for 1.5 years.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.